Chad Harman on NeuroDirect Ketamine Cream for PTSD and Depression

Chad Harman is a leading figure in the field of mental health treatments using psychedelic medicines. He is the driving force behind a bioscience company that is focused on developing precise and targeted dosing control technologies for psychedelics. With years of experience in the industry, Chad has identified the primary issues that need to be addressed, such as the side effects that can arise from using such powerful medicines. He is dedicated to bringing these technologies through the FDA clinical trial pathway, and he is committed to making mental health treatments more effective and accessible to patients who need them.